Short Bowel Syndrome: all 151 studies

Page 2 of 2. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.

• Probiotics in Short Bowel SyndromeCompletedNCT03980327Not applicable
• Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBSCompletedNCT03905707Phase 3
• Intralipid Versus SMOFlipid in HPN PatientsCompletedNCT03773237Not applicable
• Use of Tocofersolan (Vedrop®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and ChildrenWithdrawnNCT03582384Phase 2
• Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric PatientsCompletedNCT03562130Phase 4
• Effects of an Amino Acid Mixture on Gastrointestinal Function, Inflammation and Fluid Balance: A Pilot Study in Patients With Inflammatory Bowel DiseaseTerminatedNCT03451253Not applicable
• Effect of a Short Message Service Intervention on Patients With Short Bowel SyndromeTerminatedNCT03419156Not applicable
• Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral SupportCompletedNCT03415594Phase 1/2
• Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal InsufficiencyCompletedNCT03408132Phase 1/2
• Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)WithdrawnNCT03371862Phase 2
• Sham Feeding Post-operative InfantsCompletedNCT03350022Not applicable
• Osmolality of Oral Supplements and Ileostomy OutputCompletedNCT03348709Not applicable
• SMOFLipid in Patients Who Are Intralipid IntolerantWithdrawnNCT03054948Phase 4
• Teen and Young Adult Connections for Support From Multidisciplinary Professionals & PeersCompletedNCT02987569Not applicable
• A Study to Monitor the Use of an Amino Acid-Based Infant FormulaCompletedNCT02953223
• Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different ComplicationsCompletedNCT02699320
• A Phase 2 Trial Testing ZP1848 in Patients With SBSCompletedNCT02690025Phase 2
• A Trial to Investigate the Effect of Different Supplements on Fluid and Sodium Status in Short BowelCompletedNCT02686606Not applicable
• The Use of DPP-4 Inhibitors in Short Bowel SyndromeTerminatedNCT02653131Phase 4
• Measurement of Body Composition by Air Displacement Plethysmography in Pediatric Intestinal Failure PatientsCompletedNCT02561819
• Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over StudyTerminatedNCT02266849Phase 3
• A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001WithdrawnNCT02246816Phase 3
• A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-DiarrhealsWithdrawnNCT02242656Phase 3
• Comparison of Different Oral Rehydration SolutionsCompletedNCT02142582Not applicable
• Energy Metabolism in Patients With Short Bowel SyndromeCompletedNCT02113228
• Registry for Participants With Short Bowel SyndromeActive, not recruitingNCT01990040
• The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome PatientsCompletedNCT01974336Phase 4
• Infant & Toddler Short Gut Feeding Outcomes StudyCompletedNCT01946503
• Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care ResearchCompletedNCT01900288Not applicable
• Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?CompletedNCT01891279Not applicable
• Safer Parenteral Nutrition in Pediatric Short Bowel Syndrome to Decrease Liver DamageApproved for marketingNCT01861834
• Exenatide on GI Motor Function and Permeability in Short Bowel SyndromeWithdrawnNCT01818648Phase 4
• Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver DiseaseStatus unknownNCT01739517Phase 2
• Prescription Pattern of Adjuvant Drugs and Vitamins in Patients Undergoing Long-term Home Nutritional Support for Intestinal InsufficiencyCompletedNCT01696656
• Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal FailureTerminatedNCT01573286Phase 1/2
• Evaluation of 70% Ethanol Lock Solution to Prevent Catheter Related Blood Stream Infections in Pediatric PatientsWithdrawnNCT01409772
• Early Provision of Enteral Microlipid and Fish Oil to Infants With EnterostomyCompletedNCT01306838Early Phase 1
• Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver DiseaseApproved for marketingNCT01297933
• Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel SyndromeWithdrawnNCT01263574Phase 2
• Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and ChildrenCompletedNCT01194063Phase 3
• Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver DiseaseWithdrawnNCT01191177Phase 1/2
• Magnetic Resonance (MR) Enterography Assessment of Post Operative Small Bowel Length in Short Bowel Syndrome PatientsStatus unknownNCT01183793Not applicable
• Fiber Use in Pediatric Short Bowel SyndromeWithdrawnNCT00922805Not applicable
• Pharmacokinetics of Citalopram in Patients With Short Bowel SyndromeWithdrawnNCT00876226Not applicable
• Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?Status unknownNCT00793195Phase 2
• Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel SyndromeStatus unknownNCT00673751Not applicable
• Mechanisms of Adaptation in Human Short Bowel SyndromeCompletedNCT00248573
• Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal FailureCompletedNCT00180648
• Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel SyndromeCompletedNCT00169637Phase 3
• Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease PatientsCompletedNCT00138879
• Diet/Growth Factor Mechanisms of Gut AdaptationCompletedNCT00067860Phase 2

← Short Bowel Syndrome overview